JBDI said Nasdaq closed its bid-price deficiency case on July 15, 2026 after a prior delisting warning; the company will remain listed on the Nasdaq Capital Market under ticker JBDI.
JBDI Holdings Limited said it regained compliance with Nasdaq Listing Rule 5550(a)(2), the exchange’s $1 minimum bid-price requirement, after previously receiving a delisting warning tied to its share price falling below $1. Nasdaq had told the company in a July 9, 2026 determination letter that it had failed to regain compliance within the 180-day cure period running from January 7, 2026 to July 6, 2026, and that it was not eligible for a second 180-day extension because it did not meet the minimum stockholders’ equity initial listing requirement for the Nasdaq Capital Market. JBDI said Nasdaq then sent a separate notice on July 15 confirming the company had regained compliance, allowing its ordinary shares to remain listed under the symbol JBDI.